27 Martin AM, Nirschl TR, Nirschl CJ, et al. Paucity of PD- L1 expression in prostate cancer: innate and adaptive immune resistance. Prostate Cancer Prostatic Dis 2015;18:325–32. 28 Calagua C, Russo J, Sun Y , et al. Expression of PD- L1 in Hormone- naïve and treated prostate cancer patients receiving neoadjuvant abiraterone acetate plus prednisone and leuprolide. Clin Cancer Res 2017;23:6812–22.